In a distant aftershock of last year’s AIDS vaccine failure from Merck, the federal government said yesterday that it’s canceling an ambitious plan for a global test of another experimental AIDS vaccine.
The vaccine, created by an NIH researcher, uses a cold virus as part of its delivery mechanism. The same virus was implicated in the failure of Merck’s vaccine — which may actually have made some people more susceptible to infection by HIV, the virus that causes AIDS.
More Glum News for AIDS Vaccines [WSJ Health Blog]
